HomeAnswersSurgical Oncologybladder cancerMy father was diagnosed with muscle-invasive bladder cancer. Is it advisable to remove the bladder?

How long can a person live with muscle-invasive bladder cancer?

Share

The following is an actual conversation between an iCliniq user and a doctor that has been reviewed and published as a Premium Q&A.

Answered by

Dr. Arvind Guru

Medically reviewed by

Dr. Sneha Kannan

Published At November 4, 2021
Reviewed AtOctober 20, 2022

Patient's Query

Hi doctor,

My father was diagnosed with muscle-invasive bladder cancer seven months back and some enlarged local nodes, and then three months back, it moved to his sacrum bone. He received four cycles of Gem (gemcitabine)/Cis (cisplatin) over the course of three months. Last month, he was scheduled for surgery but came down with COVID-19, so it was postponed to today. Yesterday his PET (positron emission tomography) scan revealed many new findings. We are still removing the bladder because of his severe symptoms, and then we will be starting immunotherapy and radiation treatments in a couple of weeks. What do you think? And how long can one expect to live with these results?

Impression: 1. Redemonstrated asymmetric thickening of the bladder dome and left lateral wall, keeping with the primary site of disease. 2. New multiple FDG-avid lung nodules, most likely representing metastasis. 3. Increased retroperitoneal and bilateral pelvic metastatic lymphadenopathy. 4. Increased extent of the sacral osseous lesion with pathologic fracture, representing metastatic disease. 5. The additional FDG uptake (radiotracer uptake) in the L1 spinous process may represent osseous metastasis. However, posttraumatic change can demonstrate a similar finding. 6. Small but FDG-avid left mediastinal lymph nodes are indeterminate, may represent metastasis. 7. Focal increased FDG uptake in the right side of the root of the penis without definite CT correlate may represent metastatic disease.

Answered by Dr. Arvind Guru

Hi,

Welcome to icliniq.com.

I have reviewed the information (attachment removed to protect patient identity) provided.

In my very limited opinion (as I have not seen the patient myself, and there can be other information that has been omitted in this query), surgery in the form of Complete Bladder removal is usually not required in Metastatic Bladder Cancer.

Even for symptom relief, minimal surgery and Radiation are usually preferable.

Regarding survival, we need to consider the performance status of the patient, to begin with. Moreover, the response to chemotherapy is also very important. In your case, the disease is progressive on first-line chemo. This makes disease control a very difficult goal to achieve.

Immunotherapy and Radiation cannot eradicate the disease completely.

So overall, I am afraid it is not a promising situation. To the best of my belief, the five-year survival is around 5 %, and Immunotherapy might brace that up by a small percentage.

Participation in a running clinical trial might be the best treatment option for him.

Still, this is a very limited opinion, do verify it with your doctor.

Same symptoms don't mean you have the same problem. Consult a doctor now!

Dr. Arvind Guru
Dr. Arvind Guru

General Surgery

Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Ask your health query to a doctor online

Surgical Oncology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy